U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
8559185591Alternative Dosing Strategy of Ruxolitinib in Patients With MyelofibrosisCompletedHas ResultsPrimary Myelofibrosis|Post-Polycythemia Vera Myelofibrosis|Post-Essential Thrombocythemia MyelofibrosisDrug: Ruxolitinibhttps://ClinicalTrials.gov/show/NCT01445769
8559285592Topical Lidocaine for Pain Control With Intrauterine Device (IUD) InsertionCompletedNo Results AvailablePainDrug: Lidocaine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01445756
8559385593Immunogenicity and Safety of an Acellular DPT Vaccine During PregnancyCompletedNo Results AvailablePregnancyBiological: Biological/Vaccine: Tdap Vaccinehttps://ClinicalTrials.gov/show/NCT01445743
8559485594Fructose Consumption and Metabolic DysregulationActive, not recruitingNo Results AvailableCentral Obesity|HypertriglyceridemiaDietary Supplement: Fructose|Dietary Supplement: Fructosehttps://ClinicalTrials.gov/show/NCT01445730
8559585595Rapid Diagnostic Test for Detection of Group B Streptococcus in PregnancyCompletedNo Results AvailableStreptococcus Infection|Pregnancyhttps://ClinicalTrials.gov/show/NCT01445717
8559685596Use of Probiotics to Aid in Weight LossCompletedNo Results AvailableWeight LossDietary Supplement: Probiotics|Dietary Supplement: Placebohttps://ClinicalTrials.gov/show/NCT01445704
8559785597More Complete Removal of Malignant Brain Tumors by Fluorescence-Guided SurgeryRecruitingNo Results AvailableBenign Neoplasms, Brain|Brain Cancer|Brain Neoplasms, Benign|Brain Neoplasms, Malignant|Brain Tumor, Primary|Brain Tumor, Recurrent|Brain Tumors|Intracranial Neoplasms|Neoplasms, Brain|Neoplasms, Intracranial|Primary Brain Neoplasms|Primary Malignant BraiDrug: 5-ALA (Gliolan)https://ClinicalTrials.gov/show/NCT01445691
8559885598Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Meropenem in Complicated Intraabdominal InfectionsCompletedHas ResultsComplicated Intra-abdominal InfectionDrug: CXA-201 and metronidazole|Drug: Meropenemhttps://ClinicalTrials.gov/show/NCT01445678
8559985599A Lifestyle Investigation With Spectacles and Daily Disposable Contact Lenses in Young PatientsCompletedHas ResultsMyopiaDevice: nelfilcon A contact lens|Other: Spectacleshttps://ClinicalTrials.gov/show/NCT01445652
8560085600Dexmedetomidine in Patients After Intracranial SurgeryCompletedNo Results AvailableCentral Nervous System DiseasesDrug: Dexmedetomidine|Drug: Normal salinehttps://ClinicalTrials.gov/show/NCT01445639
8560185601A Retrospective Data Collection Study in Patients Receiving Dexamethasone Intravitreal Implant (Ozurdex®) for Macular Oedema Due to Retinal Vein Occlusion (RVO)CompletedHas ResultsMacular EdemaDrug: dexamethasone intravitreal implant 0.7 mghttps://ClinicalTrials.gov/show/NCT01445626
8560285602Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid EndarterectomyActive, not recruitingNo Results AvailableCarotid Artery Disease|Stroke|Amaurosis Fugax|Transient Ischemic Attack (TIA)Device: RX Acculink Carotid Stent System (RX Acculink)https://ClinicalTrials.gov/show/NCT01445613
8560385603ALTARGO(Retapamulin) PMS(Post-marketing Surveillance)CompletedNo Results AvailableSkin Infections, BacterialDrug: ALTARGO(retapamulin)https://ClinicalTrials.gov/show/NCT01445600
8560485604A Study of GSK2110183 in Subjects With Proteasome Inhibitor Refractory Multiple MyelomaWithdrawnNo Results AvailableCancerDrug: Part 1; Cohort 1|Drug: Part 1; Cohort 2|Drug: Part 2; Stage 1|Drug: Part 2, Stage 2https://ClinicalTrials.gov/show/NCT01445587
8560585605Ultra Low Dose Interleukin-2 in Healthy VolunteersCompletedNo Results AvailableHematologic DiseasesDrug: Interleukin-2 (100,000 international units)|Drug: Interleukin-2 (200,000 international units)https://ClinicalTrials.gov/show/NCT01445561
8560685606Sirolimus for Advanced Age-Related Macular DegenerationCompletedHas ResultsAge-Related Macular Degeneration|Geographic AtrophyDrug: Sirolimushttps://ClinicalTrials.gov/show/NCT01445548
8560785607Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell LymphomasActive, not recruitingNo Results AvailableT-Cell Peripheral Lymphoma|Gamma Delta Hepatosplenic T-Cell Lymphoma|Subcutaneous Panniculitis-Like T-Cell Lymphoma|NK T-Cell LymphomaBiological: Rituximab|Drug: EPOCH|Biological: Siplizumabhttps://ClinicalTrials.gov/show/NCT01445535
8560885608ABT-888 Plus Metronomic Cyclophosphamide to Treat CancerCompletedNo Results AvailableNeoplasms|LymphomaDrug: ABT-888|Drug: Cyclophosphamidehttps://ClinicalTrials.gov/show/NCT01445522
8560985609Dasatinib in Combination With Bevacizumab to Treat Advanced Solid TumorsActive, not recruitingNo Results AvailableSolid TumorsDrug: Bevacizumab|Drug: Dasatinibhttps://ClinicalTrials.gov/show/NCT01445509
8561085610Neuropsychological Changes in Patients Receiving Radiation Therapy for Brain MetastasesRecruitingNo Results AvailableBrain Metastasis|Cancerhttps://ClinicalTrials.gov/show/NCT01445483
8561185611Habit Reversal Training for Children and Adolescents With TrichotillomaniaActive, not recruitingNo Results AvailableTrichotillomaniaBehavioral: Habit Reversal Traininghttps://ClinicalTrials.gov/show/NCT01445444
8561285612A Trial on the Efficacy and Safety of Virgin Coconut Oil Compared to Mineral Oil in the Treatment of Uremic XerosisCompletedNo Results AvailableUremic XerosisOther: Virgin Coconut Oil|Other: Mineral Oilhttps://ClinicalTrials.gov/show/NCT01445431
8561385613AZD2281 Plus Carboplatin to Treat Breast and Ovarian CancerActive, not recruitingNo Results AvailableBreast Cancer|Ovarian CancerDrug: AZ2281 + Carboplatinhttps://ClinicalTrials.gov/show/NCT01445418
8561485614Radiation Therapy and Bortezomib and Cetuximab With or Without Cisplatin to Treat Head and Neck CancerCompletedNo Results AvailableCarcinoma, Squamous|Head and Neck Cancer|Oral Cancer|Laryngeal Cancer|Pharyngeal CancerDrug: Bortezomib (Velcade, PS-341)|Drug: Cetuximab|Drug: Cisplatin|Procedure: Radiation Therapyhttps://ClinicalTrials.gov/show/NCT01445405
8561585615SS1(dsFV)PE38 Plus Pemetrexed and Cisplatin to Treat Malignant Pleural MesotheliomaActive, not recruitingNo Results AvailableMesotheliomaBiological: Multicycle SS1P|Drug: Pemetrexed|Drug: Cisplatin|Biological: Single cycle SS1Phttps://ClinicalTrials.gov/show/NCT01445392
8561685616Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant CancerCompletedNo Results AvailableSarcoma|Wilm's Tumor|Lymphoma|NeuroblastomaDrug: Ipilimumabhttps://ClinicalTrials.gov/show/NCT01445379
8561785617Solute Removal With High Volume Hemodiafiltration Versus Long High Flux HemodialysisRecruitingNo Results AvailableEnd-stage Renal DiseaseDevice: High volume post dilution hemodiafiltration|Device: high flux hemodialysishttps://ClinicalTrials.gov/show/NCT01445366
8561885618Topical Romidepsin to Treat Early-Stage Cutaneous T-Cell LymphomaTerminatedNo Results AvailableMycosis Fungoides|Cutaneous T-Cell Lymphoma|NeoplasmsDrug: Romidepsin (FR901228)https://ClinicalTrials.gov/show/NCT01445340
8561985619Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal CancersTerminatedNo Results AvailableEsophageal Cancer|Stomach Cancer|Pancreatic Cancerhttps://ClinicalTrials.gov/show/NCT01445327
8562085620Analysis of Data Collected From Individuals Administered Neurobehavioral AssessmentsEnrolling by invitationNo Results AvailableHIV|Brain Tumors|Neurofibromatosis 1https://ClinicalTrials.gov/show/NCT01445314

* Görseller ve İçerik tekif hakkına sahip olabilir